Clinical Study
Low Serum Concentration of Obestatin as a Predictor of Mortality in Maintenance Hemodialysis Patients
Table 1
Comparison between subjects with lower and higher serum obestatin levels stratified by the median of obestatin in the study population ().
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Continuous variables are expressed as mean ± SD or as median with 25th to 75th percentile shown in parentheses in cases of nonnormally distributed data, and categorical variables are expressed as a percentage. Assessed by 2 test. Compared by the nonparametric Mann-Whitney test. DM: diabetes mellitus; CV: cardiovascular; SBP: predialysis systolic blood pressure; DBP: predialysis diastolic blood pressure; nPNA: normalized protein nitrogen appearance; TLC: total lymphocyte count; IL-6: interleukin-6; TNF-α: tumor necrosis factor-α; BMI: body mass index; TSF: triceps skinfold thickness; MAC: midarm circumference; MAMC: midarm muscle circumference calculated; ECW/TBW: extracellular water to total body water ratio; FMI: fat mass index; and FFMI: fat-free mass index. |